U.S Class(es): 005, 006, 018, 044, 046, 051, 052
Class Status: Active
Name | Laurence Rickles TEVA PHARMACEUTICALS USA, INC. |
---|---|
Address | 400 INTERPACE PARKWAY BUILDING A PARSIPPANY, NJ 07054 United States |
Date | Description | Action Tags | Code |
---|---|---|---|
Feb-03-2023 | NEW APPLICATION ENTERED | NWAPI | |
Feb-17-2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
Oct-30-2023 | ASSIGNED TO EXAMINER | DOCKD | |
Oct-31-2023 | EXAMINERS AMENDMENT -WRITTEN | CNEAR | |
Oct-31-2023 | EXAMINERS AMENDMENT E-MAILED | GNEAF | |
Oct-31-2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | GNENO | |
Oct-31-2023 | EXAMINER'S AMENDMENT ENTERED | XAECI | |
Oct-31-2023 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAP | |
Nov-15-2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | NONPE | |
Dec-05-2023 | PUBLISHED FOR OPPOSITION | PUBOA | |
Dec-05-2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | NPUBE | |
Jan-30-2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | NOAME | |
Jul-24-2024 | SOU TEAS EXTENSION RECEIVED | EEXTI | |
Jul-24-2024 | SOU EXTENSION 1 FILED | EXT1S | |
Jul-24-2024 | SOU EXTENSION 1 GRANTED | EX1GS | |
Jul-24-2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | EXRAE |